Results reading: Half-year Results
The August statement said trading was 'in line' with expectations and profitability was coming earlier. The half-year results go further: trading is 'ahead' of the Board's expectations, the full-year outcome is now guided above market expectations, and the order backlog runs beyond two years. The profit behind this is thin (£0.19m operating profit, about £0.05m without a one-off £0.14m item), cash fell £1.85m since March, inventories rose against the stated expectation, and the 5p interim dividend is far from covered by earnings.
What changed against what was known
-
Better
Trading for the half is now described as ahead of Board expectations, an upgrade from the 'in line' revenue described in the August AGM statement.
-
New
For the first time the Board guides the full-year result above current market expectations, with H2 expected to improve both on H1 and on the prior year.
Then · 17 Jun 2026 · Final Results“For FY27 the Board expects to see a return to revenue growth.” -
New
Visibility has improved sharply: book-to-bill is well above one, the backlog extends beyond two years and the pipeline is put at over £190m lifetime value. The commitments come from 'key customers', so concentration is likely but not quantified.
“As a result, medium-term revenue visibility has markedly improved, with an order backlog now extending beyond the next two years, while the steadily expanding opportunity pipeline has a total lifetime value, measured on a prudent basis, exceeding £190 million.” -
Worse
Inventories rose to £5.41m from £4.76m at March, against an earlier expectation that stock levels would keep falling. Management says the record order intake and multi-year support needs required rebuilding security of supply.
“At 30 September 2026, inventories were valued at £5.41m (31 March 2026: £4.76m).”
2 points only confirm what the company said before
- The half-year operating profit of £0.19m (against a £0.98m loss a year earlier) delivers the return to operational profitability the August statement pointed to, though the margin is very thin. “A pre-exceptional £0.19m profit from operations was recorded compared to a prior year pre-exceptional operating loss of £0.98m.”
- The £30m+ GNSS chip contract is on plan, with design tracking to plan and production targeted for calendar 2028. This fits the 2-3 year design phase described in June. “The contract is valued at over $30m, with design of the chip tracking to plan and production availability targeted for calendar year 2028.”
What the notes say – not in the headline numbers
The Group now holds £683,000 of contract liabilities on design and development work (nil at March) and its contract assets fell to £13,000 from £265,000. Cash still fell from £12.80m to £10.95m after R&D spend, the final dividend and a deferred consideration payment.
Customer prepayments for design work are cushioning cash, and they unwind as the work is delivered, so the cash fall would have been larger without them.
“The Group has contract assets of £13,000 as at 30 September 2026 (£265,000 at 31 March 2026) from design and development and contract liabilities of £683,000 as at 30 September 2026 (£Nil at 31 March 2026) from design and development.”Other operating income of £0.35m includes a £0.14m one-off precious metal reclamation. Without it, the £0.19m operating profit would be about £0.05m.
The first-half return to operating profit leans on a non-recurring item, so underlying profit is close to breakeven.
“Along with an additional amount of £0.14m received from a one-off precious metal reclamation, a total other operating income figure of £0.35m was posted (H1 FY26: £0.15m).”The 5p interim dividend is held flat, against basic EPS of 1.03p for the half. In June the Board said it wanted to 'rapidly reach' payments covered by operating profit and cash flow.
The dividend is still paid out of the balance sheet rather than earnings, and net cash is £10.95m (£12.80m at March).
“The Board is declaring an interim dividend of 5p per ordinary share (H1 FY26: 5.0p), payable on 11 December 2026 to shareholders on the register on 27 November 2026.”Development costs were impaired in FY26. In H1 FY27 £1.12m of the £2.41m R&D spend was capitalised (£2.24m of £2.75m in H1 FY26), and the passages given show no headroom or budget assumptions.
Capitalised development costs stay exposed to further impairment if the new products do not convert to revenue, and the lack of disclosed headroom makes this hard to size.
“An impairment review of the carrying costs of the Group’s development expenditure took place which resulted in the development costs being impaired in the year.”No longer mentioned
Wind-down of the customer inventory overhang as a driver of recovery
Last said · 17 Jun 2026 · Final Results“Our anticipated progress is based upon a continued winding down of the customer inventory overhang along with firmer demand across the key market verticals.”
Not in this report at all – which can mean nothing, or a plan quietly dropped.
Watch at the next report
- Whether H2 revenue and operating profit rise sequentially, as guided, and whether the full-year result lands above market expectations.
- Cash, inventories and contract liabilities: whether cash stops falling and how the £683,000 of customer prepayments unwinds.
- Conversion of the two-year backlog into revenue and gross margin (64% in H1 against 67% a year earlier), plus the new CFO's start on 1 February 2027.
Read 17 Nov 2026 against the last statement, the previous results and the open promises. Quotes are the company's words; the rest is our reading. Not investment advice.